3 results match your criteria: "Pulmonary Disease Hospital of Tongji University[Affiliation]"
[Relationship between ID1 and EGFR-TKI Resistance in Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi
December 2016
Department of Oncology, Pulmonary Disease Hospital of Tongji University, Shanghai 200433, China.
Background: Non-small cell lung cancer (NSCLC) presents the highest morbidity and mortality among malignant tumors worldwide. The overall effective rate of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is 30% to 40%, and PFS (progression-free sruvival) is 12 months. However, EGFR-TKI resistance is typical in clinical observations, and this phenomenon significantly affects tumor suppression.
View Article and Find Full Text PDFVideo-assisted repair of cervical lung hernia.
Thorac Cardiovasc Surg
April 2010
The General Thoracic Surgery, the Pulmonary Disease Hospital of Tongji University, Shanghai, China.
Lung hernia is an extremely rare condition and the treatments vary. We report a case of cervical lung hernia without any trauma. The patient underwent video-assisted repair with a satisfactory result.
View Article and Find Full Text PDF[Investigation of long-term outcome for lung cancer of patients with neoadjuvant chemotherapy].
Zhonghua Wai Ke Za Zhi
July 2009
Department of Thoracic Surgery, Shanghai Pulmonary Disease Hospital of Tongji University, Shanghai 200433, China.
Objective: To evaluate and analyze prognostic factors for surgical treatment of patients with neoadjuvant chemotherapy.
Methods: Records of 256 patients who underwent operation after chemotherapy for lung cancer from June 1995 to May 2007 were reviewed retrospectively. Potential prognostic factors which were univariately and multivariately analyzed by COX proportional hazard regression model, included gender, age, p-TNM stage, size of tumor, metastasis of lymph node, histological type and operation extent.